Valuation : Jianmin Pharmaceutical Group Co.,Ltd.

Market Cap 4.15B 619M 534M 505M 458M 859M 59.16B 863M 6B 2.31B 30.1B 2.33B 2.27B 95.1B P/E 2024
17.5x
P/E 2025 14.2x
Enterprise Value 3.08B 458M 395M 374M 339M 636M 43.8B 639M 4.44B 1.71B 22.28B 1.72B 1.68B 70.41B EV / Sales 2024
1.56x
EV / Sales 2025 1.21x
Free-Float
65.51%
Yield 2024
2.16%
Yield 2025 2.68%
1 day+0.82%
1 week-3.46%
Current month-1.63%
1 month-8.91%
3 months+2.38%
6 months-14.14%
Current year-19.33%
1 week 26.51
Extreme 26.51
28.22
1 month 26.51
Extreme 26.51
30.13
Current year 24.68
Extreme 24.68
35.87
1 year 24.68
Extreme 24.68
42.62
3 years 24.68
Extreme 24.68
72.3
5 years 24.68
Extreme 24.68
86.78
10 years 13.69
Extreme 13.69
86.78
Manager TitleAgeSince
President 50 09/09/2020
Director of Finance/CFO 54 02/01/2018
Compliance Officer 38 -
Director TitleAgeSince
Chairman 39 17/09/2019
Director/Board Member 55 03/08/2011
Director/Board Member 55 06/09/2013
Date Insider Type Main position Quantity % Market Cap. Importance
13/12/21 Sell

Chairman

5,000 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+0.82%-3.46%-36.03%-57.49% 619M
-0.65%-2.93%+47.70%+86.17% 994B
-0.29%-3.51%+49.15%+62.35% 640B
+0.83%+0.26%+17.76%+72.25% 454B
-0.38%-3.59%+30.13%+35.17% 337B
-0.09%-13.54%+13.34%+24.95% 261B
-0.43%-2.48%-0.73%+9.58% 246B
-1.34%-13.70%+36.53%+44.96% 204B
-3.44%-7.51%-20.63%-59.44% 190B
-0.75%-4.82%+25.46%+87.14% 178B
Average -0.57%-5.47%+16.27%+30.56% 350.54B
Weighted average by Cap. -0.51%-4.42%+30.95%+54.93%

Financials

2024 2025
Net sales 3.5B 522M 450M 426M 386M 725M 49.91B 728M 5.06B 1.95B 25.39B 1.96B 1.92B 80.24B 3.37B 502M 433M 410M 371M 697M 47.99B 700M 4.87B 1.87B 24.41B 1.89B 1.85B 77.15B
Net income 362M 53.99M 46.51M 44.04M 39.92M 74.89M 5.16B 75.27M 523M 201M 2.62B 203M 198M 8.29B 360M 53.64M 46.21M 43.76M 39.66M 74.41M 5.12B 74.79M 520M 200M 2.61B 201M 197M 8.24B
Net Debt -942M -140M -121M -115M -104M -195M -13.41B -196M -1.36B -523M -6.82B -527M -516M -21.56B -1.08B -161M -139M -131M -119M -223M -15.36B -224M -1.56B -599M -7.81B -604M -591M -24.69B
Logo Jianmin Pharmaceutical Group Co.,Ltd.
Jianmin Pharmaceutical Group Co Ltd, formerly Wuhan Jianmin Pharmaceutical Groups Co Ltd, is a China-based company principally engaged in the research and development, manufacturing, wholesale and retail of pharmaceuticals. The Company operates its businesses through two segments. The Pharmaceutical Production and Sales segment is primarily engaged in the production of various types of Chinese patent medicines and sales to pharmaceutical distributors at all levels, including sales to the commercial division within the group that sells to non-hospitals. The Commercial segment is primarily engaged in the purchase of drugs from manufacturers and manufacturers' agents, and then distribution to lower-level distributors, sales to hospitals and retail sales in pharmacies. The Company mainly operates its businesses in the domestic market.
Employees
2,257
Date Price Change Volume
11/09/26 CN¥27.08 +0.82% 1,793,476
10/09/26 CN¥26.86 -2.50% 1,804,070
09/09/26 CN¥27.55 -2.20% 1,538,537
08/09/26 CN¥28.17 +1.00% 1,528,886
07/09/26 CN¥27.89 -0.57% 1,204,500

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600976 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!